When was icardio.ai founded?

icardio.ai was founded in 2018 and raised its 1st funding round 5 years after it was founded.

Where is icardio.ai located?

icardio.ai is headquartered in Los Angeles, United States.

Who is the current CEO of icardio.ai?

Joseph Sokol of icardio.ai. They have also founded 2 companies.

How many employees does icardio.ai have?

As of Aug 31, 2026, the latest employee count at icardio.ai is 19.

Is icardio.ai a funded company?

icardio.ai is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on 2023.

When was the latest funding round of icardio.ai?

icardio.ai's latest funding was a $***** Seed round on 2023, with participation from 1 investor. Its primary sector is Clinical Labs IT. In United States, the Clinical Labs IT sector has seen $474M in funding in 2026 to date.

Where does icardio.ai rank among its competitors?

icardio.ai ranks 94th amongst 550 active competitors, of which 109 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Eyenuk, which secured $5.61M in Apr, 2026.

Who are the top competitors of icardio.ai?

icardio.ai's top competitors include HeartFlow, Oxipit and ScreenPoint. Among them, Eyenuk secured the most recent funding round in April, 2026.

icardio.ai - 2026 Company Profile, Team, Funding & Competitors

Company Details

AI-based disease diagnosis tool for providers. The company has developed software that assists with cardiac health analysis and reporting. It comes with features for medical calculations, real-time health data modeling, performance prediction, and more.

Key Metrics

Founded Year

2018

Location

Los Angeles, United States

Stage

Seed

Total Funding

$20K in 1 round

Latest Funding Round

Seed, 2023, $*****

Investors

Techstars & 1 more

Ranked

94^th among 550 active competitors

Employee Count

19 as on Aug 31, 2026

Similar Companies

OpenEvidence & 3411 more

View icardio.ai's full profile

icardio.ai has raised a total funding of $20K over 1 round. Its latest funding round was a Seed round on 2023 for $*****. 1 investor participated in its latest round. icardio.ai has 2 institutional investors.

Here is the list of recent funding rounds of icardio.ai:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2023	1564	Seed	9281	7128	4096	8193

Access funding benchmarks and valuations. Sign up today!

View details of icardio.ai's funding rounds and investors

The founders of icardio.ai are Joseph Sokol, Aakriti G and Roman S.

Here are the details of icardio.ai's key team members:

Joseph Sokol: Ceo & Founder of icardio.ai and founder of 1 other company.
Aakriti G: Co-Founder of icardio.ai and founder of 1 other company.
Contact Info: 1 email address
Roman S: CTO & Co-Founder of icardio.ai.

View details of icardio.ai's Founder profiles and Board Members

icardio.ai's employee count trend

icardio.ai has 19 employees as of Aug 26. Here is icardio.ai's employee count trend over the years:

Uncover icardio.ai's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of icardio.ai include HeartFlow, Oxipit and ScreenPoint. Here is the list of Top 10 competitors of icardio.ai, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HeartFlow 2007, Redwood City (United States), Public	Provides cardiovascular diagnostic support using analytics	$936M	Bain Capital Life Sciences, Baillie Gifford ... & 25 others	70/100
2nd	Oxipit 2017, Vilnius (Lithuania), Acquired	Developer of medical imaging software for automated radiology diagnostic support	$6.69M	Practica Capital, CoInvest Capital & 4 others	68/100
3rd	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Siemens, Insight Partners & 3 others	64/100
4th	Optellum 2015, Oxford (United Kingdom), Series A	Provider of AI-based cancer diagnostics platform	$20.6M	IQ Capital, Luminous Ventures & 35 others	63/100
5th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Open Field Capital, Khosla Ventures & 12 others	62/100
6th	Us2.ai 2017, Singapore (Singapore), Series A	AI-powered tool for the detection of heart risk	$19.1M	EDBI, IHH Healthcare Berhad & 15 others	61/100
7th	Olea Medical 2008, La Ciotat (France), Acquired	Developer of medical diagnostic software solutions for image post-processing	$6.7M	Innovacom, Turenne Groupe & 2 others	61/100
8th	Retinai Medical 2016, Bern (Switzerland), Series B	AI-based solutions for the diagnosis of retinal diseases	$15.7M	b2venture, Venture Kick & 6 others	61/100
9th	Skin Analytics 2012, London (United Kingdom), Series B	Provider of smartphone based skin cancer detection	$32.6M	Intrepid Growth Partners, Hoxton Ventures ... & 258 others	58/100
10th	Eyenuk 2010, Los Angeles (United States), Series A	AI based retinal image analysis for diabetic retinopathy	$43M	AXA Investment Managers, Jarvis Family Investments ... & 8 others	56/100
94th	icardio.ai 2018, Los Angeles (United States), Seed	AI-based disease diagnosis tool for providers	$20K	Techstars, 100KM Ventures	35/100